MX2021010451A - Firma proteica para la diagnosis de cáncer colorrectal y/o etapa pre cancerosa del mismo. - Google Patents
Firma proteica para la diagnosis de cáncer colorrectal y/o etapa pre cancerosa del mismo.Info
- Publication number
- MX2021010451A MX2021010451A MX2021010451A MX2021010451A MX2021010451A MX 2021010451 A MX2021010451 A MX 2021010451A MX 2021010451 A MX2021010451 A MX 2021010451A MX 2021010451 A MX2021010451 A MX 2021010451A MX 2021010451 A MX2021010451 A MX 2021010451A
- Authority
- MX
- Mexico
- Prior art keywords
- diagnosis
- colorectal cancer
- protein signature
- cancerous stage
- cancerous
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382157 | 2019-03-01 | ||
| EP19382156 | 2019-03-01 | ||
| PCT/EP2020/055277 WO2020178172A1 (en) | 2019-03-01 | 2020-02-28 | Protein signature for the diagnosis of colorectal cancer and/or pre-cancerous stage thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021010451A true MX2021010451A (es) | 2021-12-10 |
Family
ID=69631636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021010451A MX2021010451A (es) | 2019-03-01 | 2020-02-28 | Firma proteica para la diagnosis de cáncer colorrectal y/o etapa pre cancerosa del mismo. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220276249A1 (https=) |
| EP (1) | EP3931571B1 (https=) |
| JP (2) | JP2022522803A (https=) |
| KR (1) | KR102769007B1 (https=) |
| CN (1) | CN113785199B (https=) |
| AU (1) | AU2020230963B2 (https=) |
| CA (1) | CA3131729A1 (https=) |
| ES (1) | ES2952139T3 (https=) |
| MX (1) | MX2021010451A (https=) |
| WO (1) | WO2020178172A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2952139T3 (es) * | 2019-03-01 | 2023-10-27 | Advanced Marker Discovery S L | Firma proteica para el diagnóstico de cáncer colorrectal y/o etapa precancerosa del mismo |
| WO2021185982A1 (en) * | 2020-03-19 | 2021-09-23 | Advanced Marker Discovery S.l. | Protein signature for screening general population for colorectal cancer and/or pre-cancerous stage thereof |
| CA3202255A1 (en) | 2020-12-21 | 2022-06-30 | Hayley WARSINSKE | Markers for the early detection of colon cell proliferative disorders |
| KR102900859B1 (ko) * | 2021-12-31 | 2025-12-17 | 주식회사 이노제닉스 | 대장암 및 대장 용종 또는 진행 선종의 선별 방법 및 그 응용 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005014386D1 (de) * | 2004-12-23 | 2009-06-18 | Roche Diagnostics Gmbh | Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome |
| CN101896817A (zh) * | 2007-12-10 | 2010-11-24 | 霍夫曼-拉罗奇有限公司 | 用于结直肠癌的标记物组 |
| CN103140760B (zh) * | 2010-07-14 | 2016-01-27 | 联邦科学与工业研究组织 | 结肠直肠癌的诊断 |
| US20140220006A1 (en) * | 2013-02-01 | 2014-08-07 | Meso Scale Technologies, Llc | Lung cancer biomarkers |
| US20160291025A1 (en) * | 2013-09-18 | 2016-10-06 | Adelaide Research & Innovation Pty Ltd | Autoantibody biomarkers of ovarian cancer |
| JP6339399B2 (ja) * | 2014-03-28 | 2018-06-06 | 学校法人北里研究所 | 卵巣明細胞腺癌細胞の検出方法、卵巣明細胞腺癌診断薬、卵巣明細胞腺癌診断用プライマー、卵巣明細胞腺癌診断用キット、及び卵巣明細胞腺癌診断用プローブ |
| EP3073268A1 (en) * | 2015-03-27 | 2016-09-28 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Biomarker panel for diagnosing cancer |
| JP2018136122A (ja) * | 2015-05-29 | 2018-08-30 | 国立研究開発法人国立がん研究センター | 膵がんを診断するための血漿バイオマーカーパネル |
| US20180160885A1 (en) * | 2016-12-13 | 2018-06-14 | Prosper Abitbol | Endoscopy based medical devices, methods, and innovations |
| KR102018205B1 (ko) * | 2017-07-24 | 2019-09-05 | (주) 바이오인프라생명과학 | 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법 |
| US10968583B2 (en) * | 2017-07-26 | 2021-04-06 | David E. Lambert | Reflective road marker |
| ES2952139T3 (es) * | 2019-03-01 | 2023-10-27 | Advanced Marker Discovery S L | Firma proteica para el diagnóstico de cáncer colorrectal y/o etapa precancerosa del mismo |
| WO2021185982A1 (en) * | 2020-03-19 | 2021-09-23 | Advanced Marker Discovery S.l. | Protein signature for screening general population for colorectal cancer and/or pre-cancerous stage thereof |
-
2020
- 2020-02-28 ES ES20706332T patent/ES2952139T3/es active Active
- 2020-02-28 EP EP20706332.2A patent/EP3931571B1/en active Active
- 2020-02-28 US US17/434,976 patent/US20220276249A1/en active Pending
- 2020-02-28 CN CN202080032932.8A patent/CN113785199B/zh active Active
- 2020-02-28 MX MX2021010451A patent/MX2021010451A/es unknown
- 2020-02-28 KR KR1020217031563A patent/KR102769007B1/ko active Active
- 2020-02-28 AU AU2020230963A patent/AU2020230963B2/en active Active
- 2020-02-28 WO PCT/EP2020/055277 patent/WO2020178172A1/en not_active Ceased
- 2020-02-28 CA CA3131729A patent/CA3131729A1/en active Pending
- 2020-02-28 JP JP2021551880A patent/JP2022522803A/ja active Pending
-
2024
- 2024-12-19 JP JP2024224464A patent/JP2025038186A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220276249A1 (en) | 2022-09-01 |
| AU2020230963A1 (en) | 2021-09-30 |
| CN113785199A (zh) | 2021-12-10 |
| EP3931571B1 (en) | 2023-06-07 |
| JP2022522803A (ja) | 2022-04-20 |
| BR112021017248A2 (pt) | 2021-11-09 |
| EP3931571C0 (en) | 2023-06-07 |
| KR102769007B1 (ko) | 2025-02-14 |
| ES2952139T3 (es) | 2023-10-27 |
| CA3131729A1 (en) | 2020-09-10 |
| JP2025038186A (ja) | 2025-03-18 |
| WO2020178172A1 (en) | 2020-09-10 |
| EP3931571A1 (en) | 2022-01-05 |
| KR20210134946A (ko) | 2021-11-11 |
| AU2020230963B2 (en) | 2026-03-12 |
| CN113785199B (zh) | 2024-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2020003071A1 (es) | Proteínas de unión multiespecíficas y mejoras con estas | |
| CY1124106T1 (el) | Συνθεσεις μεταφορεα-αντισωματος και μεθοδοι παρασκευης και χρησης αυτων | |
| MX2020009568A (es) | Anticuerpos que se unen a cd39 y sus usos. | |
| CO2021001912A2 (es) | Composiciones anti-cd112r y métodos | |
| MX2021014286A (es) | Proteinas multiespecificas. | |
| MX2021010451A (es) | Firma proteica para la diagnosis de cáncer colorrectal y/o etapa pre cancerosa del mismo. | |
| CY1123290T1 (el) | Ενωσεις και μεθοδοι χρησης | |
| SA519401522B1 (ar) | Lag-3 أجـسـام مـضـادة لـ وتـركـيـبـات | |
| MX2018009581A (es) | Inmunoglobulina con fabs en tandem y sus usos. | |
| CL2019000061A1 (es) | Anticuerpo para anti-claudin 18a2 y su utilización. | |
| EP4219559A3 (en) | Antibodies for lilrb2 | |
| CU20160101A7 (es) | Inmunoglobulina con fab en tándem | |
| DOP2016000153A (es) | Anticuerpos y fragmentos anti-vista | |
| EA201690617A1 (ru) | Комбинирование anti-lag-3-антител и анти-pd-1-антител для лечения опухолей | |
| GT201700286A (es) | Modulación y tratamiento inmunes de tumores sólidos con anticuerpos que se unen específicamente a cd38 | |
| EA201991369A1 (ru) | Модифицированные направляющие рнк | |
| CL2016002017A1 (es) | Inhibición dirigida del factor de crecimiento transformador b (tgfb). | |
| CO2017004516A2 (es) | Anticuerpos anti-ox40 humanizados | |
| TR2021016542A2 (tr) | Plazma bazlı filmler ve bunları üretme ve kullanma usulleri. | |
| MX391249B (es) | Anticuerpos anti-muc16 y sus usos. | |
| MX2019011148A (es) | Metodos de tratamiento. | |
| ECSP17011657A (es) | Conjugados de fármacos con anticuerpos anti-cdh6 | |
| EA201790413A1 (ru) | Антитела против tigit | |
| AR090973A1 (es) | Anticuerpos utiles para el diagnostico del cancer | |
| UY34656A (es) | Polimorfos de (s)?2?(1?(9h?purin?6?ilamino)propil)?5?fluor?3?fenilquinazolin?4(3h)?ona, composición y método de preparación |